Test Anxiety on Bowel Health and Constipation in Students
The Effect of Test Anxiety on Bowel Health and Constipation in University Students
This observational cross-sectional study aims to examine the relationship between test anxiety, bowel health, and constipation in university students. The study will include undergraduate students aged 18 years and older who are studying in the Physiotherapy and Rehabilitation Department at Lokman Hekim University and who are in their final examination period.
Participants will complete self-report questionnaires during a single face-to-face assessment session. Constipation status will be evaluated using the Rome IV criteria, stool form will be assessed using the Bristol Stool Scale, constipation severity will be assessed using the Constipation Severity Instrument, and test anxiety level will be assessed using the Test Anxiety Inventory. Sociodemographic characteristics and bowel-related symptoms will also be recorded.
The study does not include any intervention or treatment. The findings are expected to help better understand whether test anxiety during examination periods is associated with bowel health problems and constipation in university students.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Constipation is a common gastrointestinal problem that may affect quality of life, daily activities, and psychosocial well-being. University students may be particularly vulnerable to bowel habit changes during examination periods because of increased academic stress and test-related anxiety.
This study is designed as an observational, cross-sectional, and analytical study. It will evaluate whether test anxiety is associated with bowel health indicators and constipation among university students during the final examination period. The study will be conducted at Lokman Hekim University with undergraduate students from the Department of Physiotherapy and Rehabilitation.
After providing informed consent, participants will complete self-report forms and questionnaires in a single face-to-face assessment session. The assessment will include questions about sociodemographic characteristics, bowel habits, bowel-related symptoms, constipation status, stool form, constipation severity, and test anxiety level. No intervention, treatment, randomization, or follow-up assessment will be performed.
The study is expected to provide information about the possible relationship between psychological stress related to examinations and bowel health in university students. The findings may contribute to a better understanding of stress-related bowel problems and may support future preventive approaches for young adults.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Demet Öztürk, Phd
- Número de teléfono: +905068394288
- Correo electrónico: demett.ozturkk@gmail.com
Copia de seguridad de contactos de estudio
- Nombre: Mustafa Sarı, Phd
- Número de teléfono: +905068394288
- Correo electrónico: mustafa.sari@lokmanhekim.edu.tr
Ubicaciones de estudio
-
-
Ankara
-
Ankara, Ankara, Turquía (Türkiye), 06510
- Reclutamiento
- Lokman Hekim University, Ankara, Ankara
-
Contacto:
- Demet Öztürk, Phd
- Número de teléfono: 05068394288
- Correo electrónico: demett.ozturkk@gmail.com
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Niño
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Being an undergraduate student in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University
- Being in the final examination period during the data collection process
- Having sufficient reading and comprehension skills to complete the questionnaires independently
- Voluntarily agreeing to participate in the study after reading and signing the informed consent form
Exclusion Criteria:
- Having inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, celiac disease, colorectal cancer, or a history of major gastrointestinal surgery
- Having diagnosed irritable bowel syndrome or another organic gastrointestinal disease
- Regular use of laxatives or medications that directly affect bowel movements, such as opioids
- Having neurological diseases that may affect bowel function, such as multiple sclerosis, Parkinson's disease, or spinal cord injury
- Having had an acute gastrointestinal infection within the last month
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
University Students
Undergraduate students aged 18 years and older who are studying in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University and who are in their final examination period.
Participants will complete self-report questionnaires assessing test anxiety, bowel habits, stool form, constipation status, and constipation severity during a single face-to-face assessment session.
|
Los participantes completaron formularios de evaluación y diarios.
No se administró ninguna intervención.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Constipation Status Assessed by the Rome IV Criteria
Periodo de tiempo: Baseline (Day 1)
|
Constipation status will be assessed using the Rome IV criteria.
This outcome will be reported as a binary classification: presence or absence of constipation.
Participants will be classified as having constipation or not having constipation according to constipation-related symptoms, including reduced stool frequency, straining, hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, and need for manual maneuvers.
The Rome IV criteria will not be reported as a scale score.
|
Baseline (Day 1)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Constipation Severity Assessed by the Constipation Severity Instrument
Periodo de tiempo: Baseline (Day 1)
|
Constipation severity will be assessed using the Constipation Severity Instrument.
The scale includes 16 items and evaluates constipation-related symptoms across three subdomains: obstructive defecation, colonic inertia, and pain.
The total score ranges from 0 to 73, with higher scores indicating more severe constipation symptoms.
|
Baseline (Day 1)
|
|
Stool Form Assessed by the Bristol Stool Scale
Periodo de tiempo: Baseline (Day 1)
|
Stool form will be assessed using the Bristol Stool Scale.
The Bristol Stool Scale is a 7-point stool form classification scale ranging from Type 1 to Type 7. Type 1 indicates separate hard lumps, and Type 7 indicates watery stool with no solid pieces.
Higher scores do not indicate a better or worse outcome; lower scores generally indicate harder stool forms, while higher scores indicate looser stool forms.
Participants will be asked to select the stool type that best represents their most common stool form during the last week.
|
Baseline (Day 1)
|
|
Test Anxiety Level Assessed by the Test Anxiety Inventory
Periodo de tiempo: Baseline (Day 1)
|
Test anxiety level will be assessed using the Test Anxiety Inventory.
The scale consists of 20 self-report items evaluating cognitive, emotional, and physiological symptoms of anxiety experienced before and during examinations.
Total scores range from 20 to 80, with higher scores indicating higher test anxiety.
|
Baseline (Day 1)
|
|
Bowel Habits and Bowel-Related Symptoms
Periodo de tiempo: Baseline (Day 1)
|
Bowel habits and bowel-related symptoms will be assessed using a researcher-developed evaluation form.
The form includes questions about stool frequency, postponement of defecation, perceived bowel health, preferred toilet type, and symptoms such as abdominal pain, bloating, gas, diarrhea, nausea, vomiting, indigestion, and constipation during the last week.
|
Baseline (Day 1)
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2026032
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .